Indoor Air Quality and Health Outcomes in Employees Working from Home during the COVID-19 Pandemic: A Pilot Study

Indoor air quality (IAQ) has a substantial impact on public health. Since the beginning of the COVID-19 pandemic, more employees have worked remotely from home to minimize in-person contacts. This pilot study aims to measure the difference in workplace IAQ before and during the pandemic and its impact on employees’health. The levels of fine particulate matter (PM2.5) and total volatile organic chemicals (tVOC) were measured in the employees’offices before the COVID-19 pandemic and at homes while working from home during the pandemic using Foobot air monitors. The frequencies of six sick building syndrome (SBS) symptoms were evaluated at each period of monitoring. The result showed PM2.5 levels in households while working from home were significantly higher than in offices while working at the office for all participants (p < 0.05). The PM2.5 levels in all households exceeded the health-based annual mean standard (12 µg/m3), whereas 90% of offices were in compliance. The tVOC levels were all below the standard (500 µg/m3). We also found a higher frequency of SBS symptoms were observed while working from home as the IAQ was worse at home. This study suggested that working from home might have a detrimental health impact due to poor IAQ and providing interventions to remote employees should be considered.

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis.

INTRODUCTION: The COVID-19 pandemic has impacted biopsychosocial health and wellbeing globally. Pre-pandemic studies suggest a high prevalence of common mental disorders, including anxiety and depression in South Asian countries, which may aggravate during this pandemic. This systematic meta-analytic review was conducted to estimate the pooled prevalence of anxiety and depression in South Asian countries during the COVID-19 pandemic. METHOD: We systematically searched for cross-sectional studies on eight major bibliographic databases and additional sources up to October 12, 2020, that reported the prevalence of anxiety or depression in any of the eight South Asian countries. A random-effects model was used to calculate the pooled proportion of anxiety and depression. RESULTS: A total of 35 studies representing 41,402 participants were included in this review. The pooled prevalence of anxiety in 31 studies with a pooled sample of 28,877 was 41.3% (95% confidence interval [CI]: 34.7-48.1, I 2 = 99.18%). Moreover, the pooled prevalence of depression was 34.1% (95% CI: 28.9-39.4, I 2 = 99%) among 37,437 participants in 28 studies. Among the South Asian countries, India had a higher number of studies, whereas Bangladesh and Pakistan had a higher pooled prevalence of anxiety and depression. No studies were identified from Afghanistan, Bhutan, and Maldives. Studies in this review had high heterogeneity, high publication bias confirmed by Egger's test, and varying prevalence rates across sub-groups. CONCLUSION: South Asian countries have high prevalence rates of anxiety and depression, suggesting a heavy psychosocial burden during this pandemic. Clinical and public mental health interventions should be prioritized alongside improving the social determinants of mental health in these countries. Lastly, a low number of studies with high heterogeneity requires further research exploring the psychosocial epidemiology during COVID-19, which may inform better mental health policymaking and practice in South Asia.